companies working on glp-1 drugs Analogues Market Size, Share & Growth Drivers By 2034 GLP-1 Drug Savings: A Complete
Description
doi: 10.1016/j.bbrc.2004.01.085
Retrieved 26 December 2024
Diabetes Obes Metab 25(1):5667 Rosenstock J, Wysham C, Frias JP et al (2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Additional file 1: Fig
